ClearBridge LLC (Maryland)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
$11.6M Buy
119,295
+9,545
+9% +$929K 3.53% 5
2018
Q3
$15.3M Sell
109,750
-709,383
-87% -$98.6M 3.74% 5
2018
Q2
$798 Sell
819,133
-28,365
-3% -$28 0.01% 140
2018
Q1
$94.5M Buy
847,498
+217,043
+34% +$24.2M 2.1% 6
2017
Q4
$75.4M Sell
630,455
-227
-0% -$27.1K 1.57% 19
2017
Q3
$88.5M Sell
630,682
-196,158
-24% -$27.5M 1.91% 11
2017
Q2
$101M Buy
826,840
+149,780
+22% +$18.2M 2.13% 10
2017
Q1
$82.1M Sell
677,060
-12,817
-2% -$1.55M 1.77% 17
2016
Q4
$84.4M Buy
689,877
+308
+0% +$37.7K 1.91% 17
2016
Q3
$84.5M Buy
689,569
+98,670
+17% +$12.1M 1.61% 29
2016
Q2
$69M Buy
590,899
+216,185
+58% +$25.2M 1.37% 37
2016
Q1
$52.2M Sell
374,714
-390
-0.1% -$54.3K 1.03% 42
2015
Q4
$71.6M Sell
375,104
-11,170
-3% -$2.13M 1.37% 34
2015
Q3
$60.4M Sell
386,274
-90,820
-19% -$14.2M 1.23% 37
2015
Q2
$86.2M Buy
+477,094
New +$86.2M 1.54% 32